News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,036 Results
Type
Article (13908)
Company Profile (101)
Press Release (253027)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88354)
Career Advice (466)
Deals (15446)
Drug Delivery (67)
Drug Development (36701)
Employer Resources (49)
FDA (6320)
Job Trends (6217)
News (150770)
Policy (14095)
Tag
Academia (443)
Accelerated approval (2)
Adcomms (6)
Allergies (36)
Alliances (23296)
ALS (37)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (42)
Approvals (6359)
Artificial intelligence (113)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4374)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (648)
Cardiovascular disease (73)
Career advice (410)
Career pathing (12)
CAR-T (23)
Cell therapy (90)
Cervical cancer (4)
Clinical research (31031)
Collaboration (354)
Compensation (164)
Complete response letters (17)
COVID-19 (760)
CRISPR (22)
C-suite (129)
Cystic fibrosis (37)
Data (673)
Denatured (15)
Depression (10)
Diabetes (83)
Diagnostics (1328)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (66)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32388)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37711)
Executive appointments (407)
FDA (6767)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (218)
Gene editing (40)
Generative AI (9)
Gene therapy (102)
GLP-1 (351)
Government (1302)
Grass and pollen (3)
Guidances (26)
Healthcare (3602)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (36)
Indications (14)
Infectious disease (795)
Inflammatory bowel disease (56)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5917)
IRA (29)
Job creations (2063)
Job search strategy (374)
Kidney cancer (6)
Labor market (12)
Layoffs (182)
Leadership (4)
Legal (3451)
Liver cancer (19)
Lung cancer (87)
Lymphoma (57)
Machine learning (2)
Management (16)
Manufacturing (164)
MASH (34)
Medical device (1285)
Medtech (1287)
Mergers & acquisitions (9741)
Metabolic disorders (268)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (584)
NextGen: Class of 2025 (1591)
Non-profit (597)
Now hiring (8)
Obesity (153)
Opinion (120)
Ovarian cancer (22)
Pain (54)
Pancreatic cancer (15)
Parkinson's disease (47)
Partnered (7)
Patents (122)
Patient recruitment (30)
Peanut (10)
People (29073)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8080)
Phase II (13112)
Phase III (11774)
Pipeline (477)
Policy (72)
Postmarket research (1422)
Preclinical (3241)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (170)
Real estate (2642)
Recruiting (17)
Regulatory (10177)
Reports (14)
Research institute (568)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (38)
Series B (14)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1636)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (32)
The Weekly (30)
Vaccines (158)
Venture capitalists (14)
Weight loss (101)
Women's health (8)
Worklife (4)
Date
Today (60)
Last 7 days (299)
Last 30 days (896)
Last 365 days (11748)
2025 (3995)
2024 (12522)
2023 (14257)
2022 (19589)
2021 (20122)
2020 (19108)
2019 (14947)
2018 (11756)
2017 (13916)
2016 (13152)
2015 (15494)
2014 (12438)
2013 (10670)
2012 (11458)
2011 (11970)
2010 (10939)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (57)
Arkansas (3)
Asia (20250)
Australia (2620)
California (1802)
Canada (939)
China (249)
Colorado (71)
Connecticut (70)
Delaware (61)
Europe (39831)
Florida (342)
Georgia (39)
Idaho (9)
Illinois (204)
India (16)
Indiana (142)
Iowa (1)
Japan (97)
Kansas (58)
Kentucky (13)
Louisiana (1)
Maine (2)
Maryland (266)
Massachusetts (1550)
Michigan (30)
Minnesota (98)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (794)
New Mexico (7)
New York (539)
North Carolina (405)
North Dakota (2)
Northern California (740)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (460)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (2)
Southern California (759)
Tennessee (35)
Texas (240)
United States (7527)
Utah (36)
Virginia (79)
Washington D.C. (32)
Washington State (124)
Wisconsin (17)
267,036 Results for "elan pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway
April 25, 2025
·
4 min read
Press Releases
Onchilles Expands Leadership Team to Advance First-in-Class Pan-Cancer Therapeutics Targeting the ELANE Pathway into Clinical Trials
January 13, 2025
·
4 min read
Press Releases
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at SITC 2024
November 7, 2024
·
4 min read
Elanco to Participate in Stifel 2024 Jaws and Paws Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024.
May 21, 2024
·
1 min read
Elanco to Participate in Upcoming Investor Conferences
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.
February 22, 2024
·
1 min read
Business
Elanco Appoints Shiv O’Neill as General Counsel and Corporate Secretary
Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O’Neill as the company’s Executive Vice President, General Counsel and Corporate Secretary.
March 4, 2024
·
2 min read
Press Releases
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
April 16, 2025
·
3 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Press Releases
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
February 4, 2025
·
10 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 26,704
Next
